Royalty Report: Medical, Device, Surgical – Collection: 209561

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Medical
  • Device
  • Surgical

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 209561

License Grant
The Inventor hereby sells, transfers, assigns, conveys, sets over, grants and delivers to Buyer, the Existing Technology and all of the Inventors worldwide rights, title and interest in and to the Existing Technology for whatever purpose or purposes Buyer shall, in its sole discretion, determine, including, without limitation, the exclusive right to make, use, or sell products utilizing the Existing Technology, and also including any and all prototypes, components, patents, patent infringement claims, trademarks and trade-names relating to the Existing Technology, all to the end that Buyer, by virtue of such purchase, shall be the sole owner of the Existing Technology.
License Property
Inventor has designed, invented and produced an experimental model of a nitinol blood clot filter.

'Patent' means that U.S. patent #4,425,908—— nitinol blood clot filter (the 'Filter').

Field of Use
The agreement is for the medical industry.

IPSCIO Record ID: 6202

License Grant
The Licensor, an individual, assigned the patents for his inventions to certain pediatric cardiology medical devices and techniques and know-how to the Licensee.
License Property
Our Amplatzer occlusion devices offer minimally invasive, transcatheter treatments that have been clinically shown to be highly effective in defect closure.

Our AMPLATZER occlusion devices utilize our expertise in braiding nitinol, a metal alloy with superelastic and shape-memory characteristics, and designing transcatheter delivery systems.

IPSCIO Record ID: 2016

License Grant
The Company hereby grants to Licensee a worldwide, royalty-bearing, and exclusive license under the Subject Technology to make, have made, use, import, sell and offer for sale Licensed Products technology related to a percutaneous filter for carotid angioplasty (U.S.  Patent No. 5,695,519).

The Company is developing a percutaneous temporary filter that is mounted on a guide wire and is used to prevent stroke-causing blood clots from reaching various organs of the human body.

The filter is deployed remotely, opened within a vessel and then remotely closed, safely and reliably removed with clots intact within a mesh filter containing the entrapped material.  The size of the filter is such that blood flow is not significantly reduced through straining, but embolytic debris is caught and retained by the filter.

License Property
Subject Technology
1. U.S. Patent Number 5,695,519;
2. [Patent applications for percutaneous filters for carotid angioplasty and any patents arising out of such patent applications]
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.